Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamacher

Showing results (711-720 of 1,046) with videos related to

Pageof 105
Sort By:
Scientific Reports|October 25, 2022
Heterologously secreted MbxA from Moraxella bovis induces a membrane blebbing response of the human host cellIsabelle N Erenburg, Sebastian Hänsch, Feby M Chacko, et al.
International Journal of Neonatal Screening|January 23, 2025
Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of ImmunityClaire Klippel, Jiwoon Park, Sean Sandin, et al.
The EMBO Journal|April 8, 2025
Interferon-induced PARP14-mediated ADP-ribosylation in p62 bodies requires the ubiquitin-proteasome systemRameez Raja, Banhi Biswas, Rachy Abraham, et al.
Cancer Research|March 26, 2009
Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cellsNiels Eckstein, Kati Servan, Barbara Hildebrandt, et al.
Epilepsia|March 19, 2022
Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020Laurent M Willems, Maja Hochbaum, Johann Philipp Zöllner, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Journal of Critical Care|May 16, 2022
Comparing continuous versus categorical measures to assess and benchmark intensive care unit performanceLeonardo S L Bastos, Safira A Wortel, Nicolette F de Keizer, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Mabs|February 14, 2012
Generation and characterization of human anti-human IL-21 neutralizing monoclonal antibodiesMark F Maurer, Ursula Garrigues, Stephen R Jaspers, et al.
Pageof 105

Showing results (711-720 of 1,046) with videos related to

Sort By:
Pageof 105
Scientific Reports|October 25, 2022
Heterologously secreted MbxA from Moraxella bovis induces a membrane blebbing response of the human host cellIsabelle N Erenburg, Sebastian Hänsch, Feby M Chacko, et al.
International Journal of Neonatal Screening|January 23, 2025
Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of ImmunityClaire Klippel, Jiwoon Park, Sean Sandin, et al.
The EMBO Journal|April 8, 2025
Interferon-induced PARP14-mediated ADP-ribosylation in p62 bodies requires the ubiquitin-proteasome systemRameez Raja, Banhi Biswas, Rachy Abraham, et al.
Cancer Research|March 26, 2009
Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cellsNiels Eckstein, Kati Servan, Barbara Hildebrandt, et al.
Epilepsia|March 19, 2022
Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020Laurent M Willems, Maja Hochbaum, Johann Philipp Zöllner, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Journal of Critical Care|May 16, 2022
Comparing continuous versus categorical measures to assess and benchmark intensive care unit performanceLeonardo S L Bastos, Safira A Wortel, Nicolette F de Keizer, et al.
Cancers|November 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic SettingJohanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa, et al.
Mabs|February 14, 2012
Generation and characterization of human anti-human IL-21 neutralizing monoclonal antibodiesMark F Maurer, Ursula Garrigues, Stephen R Jaspers, et al.
Pageof 105